Cardiohepatic syndrome and its prognostic predictive ability in patients with pulmonary arterial hypertension
- 28 June 2023
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 83 (5) , 290-298
Abstract
With the development of progressive right ventricular dysfunction, pulmonary arterial hypertension (PAH) is one of the causes of type 2 cardiohepatic syndrome (CHS). Risk assessment, timely and effective management are crucial to improve survival in PAH. Thus, we aimed to evaluate the presence of CHS at diagnosis and its association with prognosis in patients with PAH. One hundred and eighteen consecutive incident patients with PAH between January 2013 and June 2021 were retrospectively included. The presence of CHS was assessed from blood tests taken during diagnostic evaluation and was defined as elevation of at least two of three cholestatic liver parameters; total bilirubin, alkaline phosphatase and gamma-glutamyl transferase. The primary endpoint was all-cause mortality. Patients were followed for a median period of 58 (32-96) months. 23.7% of the patients had CHS at diagnosis. Significantly more patients in CHS (+) group were in intermediate and high-risk categories according to 2015 ESC/ERS guideline, REVEAL 2.0 and REVEAL Lite 2 risk assessment methods (p = .02, .03 and <.001, respectively). The presence of CHS was identified as an independent predictor of mortality (HR: 2.17, 95% CI: 1.03-4.65, p = .03) along with older age (HR: 2.89, 95% CI: 1.50-5.56, p = .001) and higher WHO functional class (HR: 2.57, 95% CI: 1.07-6.22, p = .03). To conclude, presence of CHS at diagnosis in patients with PAH was associated with severe disease and poor prognosis independent of other well known risk factors. As a simple and easy parameter to assess from routinely taken blood tests, CHS should be evaluated in patients with PAH.Keywords
This publication has 18 references indexed in Scilit:
- Cardiohepatic SyndromeCurrent Heart Failure Reports, 2014
- Cardiohepatic Syndrome: Liver Injury in Decompensated Heart FailureCurrent Heart Failure Reports, 2014
- Pulmonary hypertension related to congenital heart disease: a call for actionEuropean Heart Journal, 2013
- Predictors of cardiac hepatopathy in patients with right heart failureMedical Science Monitor, 2011
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2010
- Bilirubin as a prognostic marker in patients with pulmonary arterial hypertensionBMC Pulmonary Medicine, 2010
- Pulmonary Arterial HypertensionChest, 2010
- Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure PatientsJournal of Cardiac Failure, 2010
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002